Manu Jain, MD
Pulmonary Disease · Chicago, ILNPI 1609806249
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Gilead at 54.7% of the total. Reporting peaked in 2019 at $59,516 and has fallen 89.9% since, to $5,998 in 2025. Among pulmonary disease clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $824.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$102K
- Vertex$45K
- Insmed, Inc.$24K
- AbbVie$13K
- Eli Lilly$2K
- Hill-rom Company, Inc$875
- plus $177 from 3 others
Across 38 payments — averaging $44,052 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$1.7M
What the payments were for
- Consulting fees$74,64840%
- Speaking & faculty fees$91,71549%
- Travel & lodging$17,1129%
- Food & beverage$3,7572%
- Education$360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 124 | $102,408 |
| Vertex | 54 | $44,666 |
| Insmed, Inc. | 37 | $23,866 |
| AbbVie | 5 | $13,475 |
| Eli Lilly | 1 | $1,800 |
| Hill-rom Company, Inc | 1 | $875 |
| Boehringer Ingelheim | 1 | $85 |
| Philips North America LLC | 3 | $68 |
| Terumo Medical Corporation | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veklury$46,174
- Cayston$36,990
- TRIKAFTA$25,931
- Arikayce$20,429
- SYMDEKO$11,758
- ALYFTREK$1,740
- The Vest System 205 Acute Care$875
- The Vest System Model 105 Home Care$875
- The Monarch Airway Clearance System$875
How this compares
$187,268 in reported general payments places this provider in the 95th percentile of 539 pulmonary disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $18,845 |
| Spiriva HandihalerTiotropium Bromide | 12 | $10,394 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $8,005 |
| Advair HfaFluticasone Propion/Salmeterol | 20 | $6,498 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $5,946 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $2,206 |
| Azithromycin | 67 | $1,107 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $681 |
| Omeprazole | 16 | $126 |
| Ipratropium Bromide | 11 | $126 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Chicago
- Douglas HogarthChicago$2.9M
- Steven WhiteChicago$970K
- Momen WahidiChicago$779K
- Septimiu MurguChicago$633K
- Ayodeji AdegunsoyeChicago$561K
- Ravi KalhanChicago$375K
- Brian GaribaldiChicago$356K
- Richard WunderinkChicago$178K
- Rade TomicChicago$70K
- Ajay WaghChicago$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.